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SUMMARY 
Avian encephalomyelitis virus (AEV) is a picornavirus that causes disease in poultry 
worldwide and flocks must be vaccinated for protection. AEV is currently classified 
within the hepatovirus genus since its proteins are most closely related to those of 
hepatitis A virus (HAV).  We now provide evidence that the 494 nucleotide (nt) long 
5’ untranslated region (UTR) of the AEV genome contains an internal ribosome entry 
site (IRES) element that functions efficiently in vitro and in mammalian cells.  Unlike 
the HAV IRES, the AEV IRES is relatively short and functions in the presence of 
cleaved eIF4G, it is also resistant to an inhibitor of eIF4A.  These properties are 
reminiscent of the recently discovered class of IRES elements within certain other 
picornaviruses, such as porcine teschovirus-1 (PTV-1).  Like the PTV-1 IRES, the 
AEV IRES shows significant similarity to the hepatitis C virus (HCV) IRES in 
sequence, function and predicted secondary structure.  Furthermore, mutational 
analysis of the predicted pseudoknot structure at the 3’ end of the AEV IRES lends 
support to the secondary structure we present.  AEV is therefore another example of a 
picornavirus harbouring an HCV-like IRES element within its genome and thus its 
classification within the hepatovirus genus may need to be reassessed in the light of 
these findings. 
 
INTRODUCTION 
Translation initiation on the majority of cellular mRNAs is mediated by a cap-
dependent mechanism.  The cap structure (m7GpppN) found on all cytoplasmic 
mRNAs is recognized by the translation initiation factor complex eIF4F (reviewed in 
29).  This complex contains three proteins: eIF4E which is the cap-binding protein, 
eIF4A which has RNA helicase activity and eIF4G that acts as a protein scaffold 
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between the mRNA and the 40S ribosomal subunit via its interaction with eIF3 
(reviewed in 14).  In contrast, initiation of protein synthesis on some viral mRNAs, 
for example from the picornaviruses, occurs by a cap-independent mechanism termed 
internal initiation.  In this case, translation initiation is directed by an internal 
ribosome entry site (IRES) element located within the 5’ untranslated region (UTR) of 
the viral genome (reviewed in 2). These IRES elements are large, typically 450 nt in 
length, and contain extensive secondary structure; they have been shown to interact 
with a variety of cellular proteins (2). Most of these elements work without any 
requirement for eIF4E and hence can continue to function when cap-dependent 
protein synthesis is inhibited. 
 
The picornavirus IRES elements are divided into several groups which display distinct 
secondary structures and biological properties. One group (class I) contains IRES 
elements from the entero- and rhinoviruses (e.g. poliovirus, PV) while the second 
contains the cardio- and aphthovirus IRES elements (e.g. encephalomyocarditis virus, 
EMCV). The cardio-/aphthovirus IRES elements function efficiently in the rabbit 
reticulocyte lysate (RRL) translation system.  However, the PV and rhinovirus IRES 
elements are inefficient in this system unless the reaction is supplemented with 
additional proteins, e.g. from HeLa cell extracts (6, 10). The IRES element from 
hepatitis A virus (HAV) represents a third type of IRES.  It is distinct from other 
picornavirus IRES elements in that it requires an intact eIF4F complex, including 
eIF4E, for function (1, 4). In contrast, the class I and II picornavirus IRES elements 
can function efficiently when eIF4G has been cleaved by the expression of an entero-
/rhinovirus 2A or aphthovirus L protease (5, 35). This cleavage releases the N-
terminus of eIF4G including its eIF4E binding site (reviewed in 20). The initiation 
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factor eIF4A has also been shown to be required by group I and II IRES elements 
since dominant negative mutants of this protein and inhibitors of eIF4A block their 
activity (9, 27, 39). 
 
Recently, a new group of picornavirus IRES element has been identified.  This group 
includes the IRES elements from porcine teschovirus-1 (PTV-1) Talfan strain (8, 17, 
30), simian virus 2 (SV2) and porcine enterovirus-8 (PEV-8; 9).  Strikingly, these 
IRES elements have many similarities to those from hepatitis C virus (HCV) and 
classical swine fever virus (CSFV), which both belong to the Flaviviridae.  These 
recently characterised picornavirus IRES elements are predicted to share a very 
similar structure to the HCV-type elements, including a pseudoknot near the 3’ end of 
the IRES that is critical for function (12, 18, 41).  These IRES elements are generally 
shorter than other picornavirus elements, e.g. about 280 nt in the case of the PTV-1 
IRES (8).  They can also function with cleaved eIF4G (9, 30) and, unlike the group I 
and II IRES elements, are resistant to both dominant negative mutants of eIF4A (8, 9) 
and to hippuristanol, a small molecule inhibitor of eIF4A (3).  Like the HCV IRES 
element, the PTV-1 IRES element does not require any of the eIF4 initiation factors 
for assembly of 48S initiation complexes on the RNA (28, 30, 31). 
 
Avian encephalomyelitis virus (AEV) is a picornavirus that infects young chickens, 
quails, pheasants and turkeys, causing ataxia and rapid tremors, especially in the neck. 
AEV is a worldwide problem and almost all flocks are susceptible unless they are 
vaccinated (7).  Around 4 billion birds are vaccinated worldwide each year to protect 
them from infection (Dr I Tarpey, personal communication). The AEV genome is 
7032 nucleotides (nt) in length (smaller than that of any other picornavirus). It 
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encodes a polyprotein of 2134 amino acids that is processed to the individual viral 
proteins which are most closely related to the hepatitis A virus (HAV) proteins. AEV 
has therefore been assigned to the hepatovirus genus of the picornaviruses (25). The 
5’ untranslated region (UTR) of the AEV RNA is 494 nucleotides (nt) in length, 
which is also shorter than most other picornaviruses (25). On the basis of sequence 
comparisons and secondary structure predictions it has recently been suggested that 
the AEV genome contains an HCV-like IRES element (15). 
 
Here, we describe the biological properties of the AEV 5’ UTR.  We demonstrate for 
the first time that this region contains an IRES element with clear functional 
differences from that of hepatitis A virus. We also show that the AEV IRES has 
significant functional and structural similarities to the other HCV-like picornavirus 
IRES elements.   
 
MATERIALS AND METHODS 
Reporter plasmids. 
DNA preparations and manipulations were performed using standard methods as 
described in (37) or as stated in manufacturers’ instructions.  The reporter plasmids 
pGEM-CAT/EMC/LUC containing the EMCV IRES cDNA and pGEM-CAT/LUC 
(lacking any IRES) have been described previously (35). These plasmids express from 
a T7 promoter dicistronic mRNAs encoding chloramphenicol acetyl transferase 
(CAT) and firefly luciferase (fLUC).  Plasmids containing the HAV and HCV IRES 
elements between the cyclin and influenza virus NS sequences have also been 
described previously (references 4 and 33) and were a kind gift from Richard Jackson 
(University of Cambridge, UK). 
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To obtain a single cDNA fragment corresponding to the AEV 5’UTR, overlap PCR 
was performed. Two separate AEV cDNA clones (a gift from Ian Tarpey, Intervet, 
U.K. and Dave Cavanagh, Institute for Animal Health, Compton, U. K.) were used as 
templates to amplify by PCR fragments corresponding to nt 1 to 238 and 238 to 494 
of the AEV 5’UTR using primers AEVF1 with AEVR266 and AEVF238 with 
AEVR494, respectively (Table 1).  The two purified products were mixed and used in 
a further PCR using primers AEVF1 and AEVR494 to create a single fragment 
corresponding to the full-length AEV 5’ UTR (nt 1 to 494) flanked by BamHI sites. 
The PCR product was ligated into pGEMTeasy (Promega) and from the resultant 
plasmid the AEV cDNA was released by BamHI digestion and then inserted, in both 
orientations, into similarly digested and phosphatased pGEM-CAT/LUC between the 
two open reading frames (ORFs).   The plasmid containing the AEV 5’UTR cDNA in 
the sense (genomic) orientation was designated AEVs and that containing the 
fragment in the antisense orientation was called AEVas (Figure 1A).  A further 
construct containing cDNA corresponding to the AEV 5’ UTR plus 30 nt of coding 
sequence (AEV+30) was created in a similar way using the reverse primer AEVR524 
(Table 1) rather than AEVR494 in the PCRs.  
Four other derivatives (see Figure 1) of the AEVs plasmid with truncated forms of the 
AEV 5’UTR cDNA were generated as follows:- the AEV3’∆100 fragment (AEVm1) 
was created using primers AEVF1 and AEVR394, fragment AEV3’∆200 (AEVm2) 
was produced using primers AEVF1 and AEVR294, AEV5’∆100 (AEVm3) was 
made using primers AEVF100 and AEVR494 while AEV5’∆200 (AEVm4) was 
synthesized using primers AEVF200 and AEVR494 (all primer sequences are given 
in Table 1).  The various fragments were cloned, excised with BamHI and ligated into 
the pGEM-CAT/LUC dicistronic vector to produce the illustrated plasmids (Figure 
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1A). The structures were confirmed by restriction enzyme analysis and sequencing of 
the inserts. 
 
In vitro translation reactions 
The dicistronic reporter plasmids (1µg) were assayed in the rabbit reticulocyte lysate 
(RRL) coupled transcription and translation (TNT) system (Promega) using [35S]- 
methionine as described by the manufacturer. Products were analysed by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
autoradiography. Alternatively, uncapped mRNA transcripts were produced in vitro 
using the Ambion MegaScript kit with T7 RNA polymerase, following linearization 
of the plasmid DNAs with XhoI.  Each mRNA was translated in RRL with [35S]-
methionine and products were analysed by SDS-PAGE and autoradiography. 
 
Transient expression assays.  The dicistronic reporter plasmids (2µg) described 
above were transfected into 293 or HTK-143 cells alone, or with the plasmid 
pGEM3Z/J1 (0.2µg) which expresses the swine vesicular disease virus (SVDV) 2A 
protease as previously described (36). Briefly, the plasmids were transfected into cells 
(35mm dishes) previously infected with the recombinant vaccinia virus vTF7-3, 
which expresses T7 RNA polymerase (13), using Lipofectin (8 µl; Invitrogen) and 
Optimem (192 µl; Gibco BRL). Cell lysates were prepared 20 h after transfection and 
were analysed by SDS-PAGE and immunoblotting to determine CAT and LUC 
expression and eIF4G cleavage.  Detection was achieved with anti-CAT (Sigma), 
anti-fLUC (Promega) or anti-eIF4G (gift from Simon Morley, University of Sussex, 
UK) antibodies and peroxidase-labelled anti-rabbit (Amersham) or anti-goat (Dako 
Cytomation) antibodies respectively, using chemiluminescence reagents (Pierce).  
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fLUC expression was also quantified using a firefly luciferase assay kit (Promega) 
with a luminometer. 
 
RNA secondary structure prediction 
AEV 5’ UTR sequences (EMBL accession number: AJ225173) were aligned with 
those from HCV (EMBL accession number: AB016785) and PTV-1 (EMBL 
accession number: AB038528) using Clustal W and manually edited.  Secondary 
structure elements (other than the pseudoknot) were generated in Mfold (42). 
 
Mutagenesis of the AEV cDNA 
Mutations were introduced into the predicted domain IIIe region in order to change 
the sequence in the loop region from GAUA to AAAA (nts 446-449). The plasmid 
pGEM-CAT/AEVs/LUC was used as the template for two PCR reactions, one with 
each primer set (AEVIIIeF with AEVR494 and AEVIIIeR with AEVF1 - see Table 
1). After purification the products were mixed and a further PCR was performed using 
AEVF1 and AEVR494 primers. The BamHI digested product was ligated into pGEM-
CAT/LUC as described above and the resultant plasmid named pGEM-
CAT/AEVIIIemut/LUC. The plasmid was sequenced to verify the presence of the 
expected mutations.  
Mutations within the stem sequences of the predicted pseudoknot were also created 
(termed S1mut and S2mut). For the S1mut mutant, the nts 273-275 (CUC) were 
changed to GGG and in the S2mut mutant, the nts 460-461 (CC) were changed to GG.   
The plasmid pGEM-CAT/AEVs/LUC was used as the template for the primary PCRs 
with the specific mutagenic primers and either CATForward or LUCReverse primers 
(see Table 1) as appropriate. Secondary PCRs used just the latter primers. The final 
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PCR products were purified, digested with BamHI and the ca. 500 bp fragment was 
ligated into BamHI-digested and dephosphorylated pGEM-CAT/LUC vector to 
generate pGEM-CAT/AEVmutS1/LUC and pGEM-CAT/AEVmutS2/LUC. 
Compensatory mutations were produced in the same way starting with the mutS1 or 
mutS2 plasmids as templates for the PCRs.  The mutagenic primers specified the 
compensatory mutations (Table 1).  The presence of all the expected mutations in the 
plasmids was confirmed by sequencing.   
 
Translation assays in the presence of hippuristanol 
The requirement of the AEV IRES element for eIF4A was investigated both in vitro 
and in cells using hippuristanol, a specific inhibitor of eIF4A (3). Dicistronic plasmid 
DNAs were expressed in the TNT RRL system with or without hippuristanol (10 µM; 
kind gift from Jerry Pelletier, McGill University, Canada). The products were 
analysed by 10% SDS-PAGE and autoradiography. The same plasmids were also 
assayed in HTK-143 (TK-) cells with or without the addition of 0.5µM hippuristanol; 
cell lysates were prepared after 20 h and the inhibitor was added for the final 10 h.  
 
RESULTS 
 
Identification of the IRES element within the 5’ UTR of AEV RNA.   
A dicistronic reporter plasmid was prepared in which cDNA corresponding to the 
AEV 5’ UTR (nt 1-494) was inserted between two reporter gene sequences, the first 
encoding CAT and the second encoding fLUC (AEVs; Figure 1A).  A negative 
control containing the AEV sequence in the antisense orientation was also constructed 
(AEVas). Plasmid pGEM-CAT/EMC/LUC which contains the EMCV IRES was used 
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as a positive control and the plasmid pGEM-CAT/LUC, that lacks any IRES 
sequence, was used as a negative control.  RNA transcripts were prepared from each 
of these constructs using T7 RNA polymerase and were analysed in translation assays 
in RRL. Translation of the first ORF was assessed by the level of CAT expression and 
a functional IRES element led to the expression of fLUC. Each of the mRNAs 
expressed CAT efficiently as expected (Figure 1B).  RNAs containing the EMCV 
IRES and the AEV 5’ UTR sequence in the sense orientation also efficiently 
expressed fLUC (Figure 1B), but the AEV 5’UTR was less active in this system than 
the EMCV IRES.  Only a background level of LUC expression was detected from the 
AEVas construct or the construct lacking any IRES element. Similar results were 
obtained in the RRL TNT system (data not shown). No IRES activity from the AEV 
sequence was detected in the wheat germ TNT system (data not shown). To confirm 
and extend the results from these in vitro assays, the same dicistronic plasmids were 
tested in a transient expression assay in cells.  The dicistronic plasmids were 
transfected into 293 cells and after 20 h, cell extracts were prepared and analysed by 
SDS-PAGE and immunoblotting to detect CAT and LUC expression. As expected, all 
plasmids expressed CAT efficiently. The AEV and EMCV IRES elements directed 
efficient fLUC expression (Figure 1C). LUC assays performed in parallel were 
consistent with the immunoblotting results and the AEV 5’UTR generated about 50% 
of the fLUC expression observed with the EMCV IRES in 293 cells. These results 
indicated that the AEV 5’ UTR contains an IRES element that is functional both in the 
RRL system and within cells. 
 
The AEV IRES element functions in the presence of an enterovirus 2A protease   
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The 2A protease from PV (plus other enteroviruses) and the FMDV L protease each 
inhibit cap-dependent translation by inducing the cleavage of eIF4G but these 
proteases have different effects on the various picornavirus IRES elements.  Some 
IRES elements function very efficiently both in the presence or absence of the 2A and 
L proteases, for example the EMCV IRES.  Other IRES elements, for example those 
from PV and other enteroviruses, are stimulated by these proteases within certain cell 
types, e.g. BHK cells (35).  However, the IRES from HAV, the prototype hepatovirus, 
is strongly inhibited under these conditions since it requires the intact eIF4F complex 
(4). We first studied the effect of SVDV 2A on the AEV IRES activity in cells in 
order to discover any similarity with the HAV IRES. The dicistronic plasmids were 
transfected into HTK- cells either alone, or with the pGEM3Z/J1 plasmid which 
expresses the SVDV 2A protease. After 20 h, cell extracts were prepared and analysed 
by SDS-PAGE and immunoblotting to detect CAT and LUC expression. As expected, 
all plasmids expressed CAT efficiently when transfected into cells alone, but CAT 
expression was strongly inhibited in the presence of SVDV 2A protease (Figure 2A) 
as expected. The AEV and EMCV IRES elements directed efficient fLUC expression 
in HTK- cells (Figure 2A) in both the presence and absence of the 2A protease, 
although the AEV IRES did show some inhibition. Note that the AEV IRES displayed 
higher efficiency compared to the EMCV IRES in this cell type versus the 293 cells 
(80% versus 50%; Figure 1). Confirmation of eIF4G cleavage in cells expressing the 
SVDV 2A protease was achieved by Western blot analysis for eIF4G (Figure 2B); the 
C-terminal cleavage product was observed only in the presence of the protease.  In 
addition, we compared the effect of addition of FMDV L protease on the activity of 
the AEV and HAV IRES elements in vitro. In the presence of FMDV L protease, both 
the EMCV and AEV IRES elements retained activity but the HAV IRES was severely 
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inhibited in the presence of the L protease (data not shown), in agreement with 
previous data (4). These data demonstrate that the AEV IRES directs internal 
initiation of translation which is cap-independent but it does appear that the intact 
eIF4F complex is required for optimal activity. This may be due to a direct 
requirement for binding of a component of eIF4F, or possibly to an indirect effect 
such as a requirement for an eIF4F-dependent factor.  These results also indicate that 
the AEV IRES is different from the IRES element from the other hepatovirus, HAV, 
as it functions in the presence of cleaved eIF4G.  
 
The 5’ terminal sequences of the AEV 5’UTR are not required for IRES activity.  
To define the limits of the AEV IRES, four truncated fragments were made by 
removing sequences from either end of the AEV IRES cDNA.  The residual 
sequences were inserted into the pGEM-CAT/LUC vector as described above.  Each 
plasmid was analysed within transient expression assays within HTK- cells and in 
TNT assays as above.  Deletion of 100 nt from the 5’ end of the 5’UTR (mutant 
AEVm3) had some effect on IRES activity in cells, reducing the activity to 50% of 
the wt (Figure 3). However, further deletion of 200 nt from the 5’ end (AEVm4) 
completely abolished IRES activity (Figure 3). Deletion of either 100 or 200 nt from 
the 3’ end of the AEV 5’UTR also completely inhibited IRES activity (AEVm1 and 
m2), indicating that the 3’ sequences are critical for IRES activity. Similar results 
were also obtained using TNT assays in vitro (data not shown). 
The inclusion of 30 nt of viral coding sequence downstream of the AEV 5’UTR did 
not result in enhanced IRES activity within cells or in TNT reactions (data not shown) 
suggesting that these sequences do not play a significant role in AEV IRES function. 
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Similarity between the AEV IRES and IRES elements from HCV and porcine 
teschovirus-1 (PTV-1)  
As described above, the functional properties of the AEV IRES are clearly distinct 
from those of the HAV IRES.  To examine the relationship of the AEV IRES to other 
picornavirus IRES elements, we performed sequence alignments of the AEV sequence 
using ClustalW.  We found that the AEV IRES shares a significant level of identity 
with the recently characterised PTV-1 IRES (8, 17, 30).  The PTV-1 IRES has been 
shown to resemble the IRES element from HCV, a flavivirus, and the AEV IRES also 
shares certain critical characteristics with them (Figure 4A and 4B).  Notably, the 
HCV domain IIIe is identical to a region of 12 nt within the AEV sequence. Overall, 
the AEV IRES shares 48% sequence identity with the HCV IRES and 42% identity 
with the PTV-1 IRES.  The similarities are particularly apparent in the regions 
surrounding and including the pseudoknot found in the HCV and PTV-1 IRES 
structures (Figure 4C). We therefore believe that the pseudoknot structure found in 
these IRES elements is also present in the AEV IRES. 
 
Mutational analysis of the putative domain IIIe region within the AEV IRES  
Studies on domain IIIe of the HCV IRES element have indicated that each of the 
nucleotides within the highly conserved GAUA tetraloop is crucial for HCV IRES 
activity (23, 32). This domain, together with domain IIId, plays an essential role in 
binding the 40S ribosomal subunit (18, 26, 40). A closely related sequence is also 
present within the PTV-1 IRES element although the loop sequence (GACA) has a 
single nt difference from the HCV sequence; mutations in this loop of the PTV-1 
IRES also greatly reduced IRES activity (9). To assess the importance of the GAUA 
sequence within the AEV IRES element, corresponding to the HCV domain IIIe loop, 
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we mutated this motif to AAAA.  Consistent with the results from similar mutations 
within the HCV and PTV-1 IRES elements, these changes resulted in a severely 
defective AEV IRES as assessed in cells (Figure 5A).   
  
Mutational analysis of the predicted pseudoknot region within the AEV IRES 
Evidence for pseudoknot structures within the IRES elements from HCV, CSFV and 
GBV-B has been obtained (41, 34, 12).  Furthermore, the predicted structure of an 
analogous pseudoknot within the PTV-1 IRES element has been supported by 
mutagenesis studies (8). Disruption of base-pair interactions within this structure 
resulted in severely defective HCV (41) and PTV-1 (8) IRES elements.  In order to 
test the structure of this region of the AEV IRES, mutagenesis was carried out to 
disrupt the predicted base-pairing, this was followed by the introduction of 
compensatory mutations to restore the interactions. Two sets of mutations were 
introduced into the predicted pseudoknot within the base paired stem regions (see 
Figure 4B). Mutations in stem 1 (S1) changed nt 273-275 (CUC) (which are predicted 
to base-pair with nt 471-473, GAG) to GGG. These mutations were predicted to 
disrupt these base-pair interactions. This mutant IRES was assayed within the 
CAT/IRES/LUC vector in cells. As expected (Figure 5B) the mutations in this region 
severely inhibited IRES activity.  To confirm that it was the disruption of the base-
pairing in S1 rather than the change in sequence alone that was responsible for the 
inhibition of IRES activity, compensatory mutations were introduced to restore the 
predicted base-pairing.  The nt 471-473 (GAG) within the S1 mutant were changed to 
CCC, resulting in a total of 6 nt differences from the wt sequence; these additional 
modifications resulted in restoration of IRES activity to about 60-80% of wt IRES 
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activity. These results were confirmed in RRL (data not shown) and strongly suggest 
that the predicted secondary structure is correct.  
Mutations in stem 2 (S2) changed nt 460/461 (CC) to GG, these changes were 
predicted to disrupt the interactions with nt 481/482 (GG) and hence destabilize the 
pseudoknot structure. The results from in vivo (Figure 5B) and in vitro (data not 
shown) experiments indicated that these mutations completely abrogated IRES 
activity as anticipated.   Furthermore, compensatory mutations which changed nt 
481/482 (GG) to CC, predicted to restore base-pair interactions, efficiently 
regenerated IRES activity (about 60 % of wt AEV IRES activity in vivo, see Figure 5 
B). These results also supported the predicted pseudoknot structure shown in Figure 4.  
The fact that full restoration of IRES activity was not achieved may suggest that these 
nucleotides are also involved in other interactions (such as RNA-protein interactions) 
as well as forming the pseudoknot structure. 
 
The AEV IRES is resistant to hippuristanol, an inhibitor of eIF4A 
In previous studies it has been found that the HCV and PTV-1 IRES elements have no 
requirement for eIF4A for translation initiation (3, 28, 30). As the results presented 
above indicated that the AEV IRES element resembles these IRES elements, the 
requirement for eIF4A was studied in vitro and in vivo using hippuristanol, a specific 
inhibitor of eIF4A.  Hippuristanol inhibits cap-dependent translation as well as the 
activity of type I and II picornavirus IRES elements. In contrast, the activity of the 
HCV and PTV-1 IRES elements is resistant to this inhibitor (3). Selected dicistronic 
reporter plasmids were assayed in cells in the presence and absence of hippuristanol. 
As expected, the eIF4A inhibitor severely reduced translation of the upstream cistron 
CAT (Figure 6A). As seen before (9), the EMCV IRES activity was also reduced to 
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about 10% of its activity in the presence of the eIF4A inhibitor.  In contrast, the AEV 
IRES displayed marked resistance to this inhibitor (Figure 6A). Similar results were 
also observed in vitro (Figure 6B).  However, we did note that the AEV IRES was 
partially inhibited in the presence of this inhibitor in both systems (reduced to about 
50% activity in the presence of hippuristanol, which is similar to the reduction seen in 
the presence of the SVDV 2A protease) although a similar effect was also observed 
with the HCV IRES element (Figure 6B).  In contrast, the HAV IRES was completely 
inhibited in the presence of hippuristanol, a previously unreported finding (Figure 
6B). This result is in agreement with the suggestion that the HAV IRES requires the 
whole eIF4F complex for its function (4).   
 
DISCUSSION 
The studies presented here demonstrate that the 5’ UTR of the AEV genome contains 
an IRES element that functions efficiently in RRL and in mammalian cells.  Until 
recently, picornavirus IRES elements were classified into one of three groups. 
However, a new group of picornavirus IRES elements has recently been described 
which includes IRES elements that closely resemble the HCV IRES elements - these 
include elements from PTV-1, PEV-8 and SV2 (8, 9, 17, 30). From database searches 
of sequences, other picornavirus genomes, including AEV, duck hepatitis virus-1 
virus and Seneca valley virus, have recently been predicted to contain HCV-like IRES 
elements (see 9, 15). Here, we describe the functional analysis of the IRES from AEV 
and propose that this IRES element is included within this same group.   
We have shown that the functional AEV IRES lies within nts 100-494 of the 5’UTR. 
In contrast to the PV, EMCV or HAV IRES elements the AEV IRES lacks a 
polypyrimidine tract near the 3’ end of the element. It can function when eIF4G is 
 17
cleaved and is also resistant to hippuristanol, an inhibitor of eIF4A activity. These 
features distinguish the AEV IRES from these picornavirus IRES elements but they 
are shared with the PTV-1, PEV-8 and SV2 IRES elements plus the HCV and CSFV 
IRES elements. Alignment of the nucleotide sequences of the HCV and AEV IRES 
elements confirmed that these elements share a striking similarity (about 48 % overall 
identity).  Indeed, within the HCV IIIe domain there is 100% sequence identity to a 
region of the AEV IRES (Figure 4).  The secondary structure models for the HCV-
like IRES elements include an important pseudoknot structure.  The AEV sequence is 
also proposed to form this structure (Figure 4).  We have obtained supporting 
evidence for the formation of this structure in the AEV IRES through mutational 
analysis of the sequences predicted to form the pseudoknot. Mutations within the S1 
or S2 regions that were expected to disrupt the predicted pseudoknot structure 
inhibited IRES activity but compensatory mutations designed to restore the base-
pairing in this structure efficiently rescued activity.  Mutation of the GAUA motif 
within a portion of the AEV sequence that is identical to the domain IIIe of the HCV 
IRES also disrupted AEV IRES activity.  Mutation of this loop region in the HCV and 
PTV-1 IRES elements also inhibited IRES activity (8, 23, 32).  It is known that the 
IIId and IIIe regions of the HCV IRES domain III interact with the 40S ribosomal 
subunit (18, 24) while the  IIIb region has been shown to interact with eIF3 (16, 18, 
38).  A recent model of initiation complex formation on the HCV IRES suggests that 
regions IIId and IIIe of the IRES bind to the 40S ribosomal subunit and this is 
followed by the interaction with eIF3 and the ternary complex (eIF2/met-tRNAi/GTP) 
to form a 48S pre-initiation complex (26).  Recent data has shown that several 
proteins of the 40S ribosomal subunit, including p40, S3a, S5 and S16 are positioned 
close to hairpin IIIe of the HCV IRES element during the early stage of translation 
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initiation (19).  It has also recently been shown that domain II of the HCV and CSFV 
IRES elements plays a role in 80S ribosome assembly on the RNA and promotes 
eIF5-induced GTP hydrolysis and eIF2/GDP release, following 48S initiation 
complex formation (21).   
The AEV IRES does not require any viral coding sequence for function and secondary 
structure predictions suggest that there is no equivalent region to the HCV IRES 
domain IV (15; Roberts, unpublished data).  There are some differences between the 
picornavirus “HCV-like” IRES elements in this respect, as the SV2 IRES is predicted 
to contain a domain IV region, whereas the PTV-1 and PEV-8 IRES elements do not 
(9). 
The discovery of a number of distinct picornaviruses harbouring an HCV-like IRES 
element in their 5’ UTR suggests that recombination between picornavirus and 
flavivirus genomes has occurred.  Previous work has shown that the PV IRES can be 
replaced with the HCV IRES (22) to produce a viable chimeric virus, suggesting that 
they are functionally equivalent (although mechanistically very different).  However, 
it is important to note that there are important structural differences between the 
picornavirus and HCV genomes (e.g. picornaviruses possess a 3’ poly(A) tail) that 
may be important in translation/replication.  There are also differences in the sequence 
and predicted structures of the domain II regions of the picornavirus “HCV-like” and 
HCV IRES elements which may have a role in translation and/or replication.  It 
remains to be seen if the diverse domain II structures found in the picornavirus 
“HCV-like” IRES elements have the same function or are involved in replication. 
AEV has been tentatively classified as being a member of the hepatovirus genus 
within the Picornaviridae since it has the highest degree of protein sequence identity 
to HAV.  However, its IRES element is clearly distinct from that of HAV in that it 
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functions well in the presence of cleaved eIF4G, displays resistance to an inhibitor of 
eIF4A and shares a striking similarity to the HCV-like IRES elements.  Due to these 
key differences between AEV and HAV, it is suggested that the placement of AEV 
within the hepatovirus genus should be reconsidered. 
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Table 1: Oligonucleotides used for analysis of the AEV IRES 
 
Primers Sequences 
AEVF1 ATATGGATCCTTTGAAAGAGGCCTC                  
AEVF238 TGTAGTATGGGAATCGTGTATGGGGATGA 
AEVR494 ATATGGATCCGTTTAAATTGCTACCCT 
AEVR266 TCATCCCCATACACGATTCCCATACTACA 
AEVF100 ATGGATCCTCCCGCATGGCAAGG 
AEVF200 ATGGATCCATCCCTTTGCGTTTC 
AEVR294 ATGGATCCACACCTATCCCTCTA 
AEVR394 ATGGATCCATACACCGTAACAAT 
AEVR524 ATGGATCCCTTGCCTACAGTAGA 
AEVIIIeF1 ATCCTTTCCTACTGCCTAAAAGGGTGGCGTGCCCGG 
AEVIIIeR1 ATCCGGGCACGCCCACCCTTTTAGGCAGTAGGAAAGG 
AEVS1F GGGGATGATTAGGATGGGTCGTAGAGGGATAGG 
AEVS2F TGATAGGGTGGCGTGGGCGGCCACGAGAGATT 
AEVS1R CCTATCCCTCTACGACCCATCCTAATCATCCCC 
AEVS2R AATCTCTCGTGGCCGCCCACGCCACCCTATCA 
AEVS1compF TGCCCGGCCACGACCCAT TAAGGGTAGCAA 
AEVS2compF CCACGAGAGATTAAGCCTAGCAATTTAAAC 
AEVS1compR TTG CTA CCC TTAATGGGTCGTGGCCGG GCA 
AEVS2compR GTTTAAATTGCTAGGCTTAATCTCTCGTGG 
CATForward ACACCTCCCCCTGAACCTGAAACATAAAAT 
LUCReverse CATACTGTTGAGCAATTCAC 
 
Sequences underlined indicate restriction sites included in the sequence. Nucleotides 
in bold italics are those that differ from the wt sequence. 
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FIGURE LEGENDS 
 
Figure 1: The AEV 5’UTR displays IRES activity in vitro and in vivo. (A) The 
structures of plasmids used in this study are shown.  Various fragments of the 5’ UTR 
of the AEV genome were amplified by PCR using primers containing BamHI sites, 
digested, and inserted between the CAT and LUC ORFs (at the unique BamHI site) in 
plasmid pGEM-CAT/LUC as described in Materials and Methods.  Nucleotide 
numbers corresponding to the fragments are shown. (B) In vitro translation reactions 
containing RRL and [35S]-methionine were programmed with RNA transcripts 
derived from the dicistronic plasmids containing the indicated virus sequences. 
Reaction products were analyzed by SDS-PAGE and autoradiography.  The CAT and 
LUC proteins are indicated. (C) Transient expression assay in 293 cells.  The 
dicistronic plasmids (2 µg) containing the indicated virus sequences were transfected 
into vTF7-3-infected 293 cells.  After 20 h, cell lysates were prepared and analyzed 
for CAT and LUC expression by SDS-PAGE and immunoblotting.  LUC assays were 
performed on cell extracts from three separate transfections and the results 
standardized to LUC expression directed by the EMCV IRES, which was set at 100%.  
LUC activities were normalised against CAT expression determined using a 
quantitative CAT ELISA (Roche). The mean values (+ SEM) are shown.   
 
Figure 2: The AEV IRES functions in the presence of cleaved eIF4G.  (A) 
Dicistronic plasmid DNA of the form CAT/IRES/LUC (2µg) containing the indicated 
IRES sequences were transfected into HTK- cells in the absence (-) or presence (+) of 
a plasmid encoding SVDV 2A protease (0.2µg).  After 20 h, cell extracts were 
prepared and analyzed for CAT and LUC expression as for Figure 1.  LUC assays 
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were performed on cell extracts from three separate transfections and the results 
standardized to LUC expression directed by the EMCV IRES, which was set at 100%.  
LUC activities were normalised against CAT expression as for Fig. 1. The mean 
values (+ SEM) are shown. (B) Samples were also analysed by immunoblotting to 
analyse the status of eIF4G. The C-terminal cleavage product of eIF4G is indicated 
(Ct).   
 
Figure 3: Delimitation of the AEV IRES sequences required for IRES activity.  
Dicistronic plasmids containing the AEV IRES and truncated versions of this 
sequence, AEVm1 (nt 1-294), AEVm2 (nt 1-394), AEVm3 (nt 100-494) and AEVm4 
(nt 1-394) were transfected into vTF7-3-infected HTK- cells and cell extracts 
analyzed for CAT and LUC expression as in Fig. 1.  LUC expression was also 
measured by LUC assay and the results are shown below the immunoblot in arbitrary 
units.  Similar results were obtained in two independent experiments. 
 
Figure 4:  Similarity between the HCV and AEV IRES elements.  (A) Alignment 
of the HCV and AEV IRES sequences.  Sequences were aligned with ClustalW and 
manually edited.  Individual domains associated with the HCV and AEV IRES 
elements are indicated above the sequence.  Bold lines indicate regions involved in 
the formation of the pseudoknot structure within the HCV IRES and AEV IRES 
elements.  The overall sequence identity from this alignment is 48.1% but note the 
100% sequence identity within the domain IIIe region.  (B) Proposed secondary 
structure of the entire AEV IRES.  Domains are labelled according to corresponding 
domains of the HCV IRES (inset).  The structure was predicted by comparative 
sequence analysis and using Mfold (42) to predict the most thermodynamically 
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favourable structures.  (C) Comparison of predicted secondary structures of the 
domain IIIe and IIIf regions of the HCV, PTV-1 and AEV IRES elements.  The two 
stems (S1 and S2) and loop regions (L1 and L2) that form the pseudoknot are shown.  
A domain IV structure is also present in the HCV IRES but not in the PTV-1 or AEV 
IRES elements.  Within the AEV sequence, the nucleotides indicated in bold are those 
that were modified in the experiments shown in Fig. 5. 
 
Figure 5: Mutation of the domain IIIe loop or pseudoknot structure results in 
loss of AEV IRES activity.  (A) Dicistronic plasmids containing the wt AEV IRES 
or the IRES containing the loop IIIe mutation were transfected into vTF7-3-infected 
HTK- cells and analyzed for CAT and LUC expression as in Fig. 1.  LUC activities 
(normalised against CAT expression) are shown and the results are the mean LUC 
vaules (+ SEM) from three experiments. (B) Dicistronic plasmids containing the 
indicated mutations within the predicted pseudoknot region were transfected into 
HTK- cells as described above and analyzed for CAT and LUC expression as in Fig. 
3. The results are representative of two independent experiments. 
 
Figure 6: The AEV IRES is resistant to an inhibitor of eIF4A. (A) Dicistronic 
plasmids containing the indicated IRES sequences were transfected into HTK- cells in 
the absence (-) or presence (+) of 0.5µM hippuristanol (Hipp.), an inhibitor of eIF4A.  
Cells were harvested after 20 h and the inhibitor added for the last 10 h of the 
incubation.  Cell extracts were analyzed for CAT and LUC expression as in Fig. 1.  
LUC assays were performed on cell extracts from three separate transfections and the 
results standardized to LUC expression directed by the EMCV IRES, which was set at 
100%.  The mean values (+ SEM) are shown. (B) Dicistronic plasmids containing the 
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indicated IRES elements were also assayed in RRL TNT in the presence of 10 µM 
hippuristanol. The HAV and HCV IRES elements are within a cyclin/NS dicistronic 
construct. All proteins are indicated.  Note the slower migration of the HCV IRES-
directed NS product compared to the HAV IRES-directed product (arrows) due to the 
inclusion of 30 nt of the HCV coding sequence in this plasmid (reference 33). 
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Domain IIIe
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nt 341
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nt 44HCV     -------------------------CCTGTGAGGAACTACTGT-CTTCACGCAGAAAGCG 
AEV     TAAGCCCCATAGAAACGAGGCGTCACGTGCCGAAAATCCCTTTGCGTTTCACAGAACCAT 
* **     **   ** * * *  * *****
HCV     TCTAGCCATGGCGTTAGTATGAGTGTCGTGCAGCCTCCAGGCCCCCCCCTCCCG-GGAGA
AEV     CCTAACCATGGGTGTAGTATGGGAATCGTGTATGGGGATGATTAGGATCTCTCGTAGAGG
*** ******   ******* *  ***** *       *        *** **  *** 
HCV     GCCATA-GTGGTCTGCGGAACCGGTGAGTACACCGGAATTGCCA---GGACGACCGG---
AEV     GATAGGTGTGCCATTCAAATCCAGGGAGTACTCTGGCTCTGACATTGGGACATTTGATGT
*  *   ***   * *  * ** * ****** * **   ** **   ****    *
HCV     GTCCTTTCTTGGATCAAT-CCCGCTCAATGCCTGGAGATTTGGGCGTGCCCCCGCGAGAC
AEV     AACCGGACCTGGTTCAGTATCCGGGTTGTCCTGTATTGTTACGGTGTATCCGTCTTGGCA
**   * *** *** *  ***     * *       **  ** **  **     *  
HCV     TGCTAGCCGAGTAGTGTTGGGTCGCGAAAGGCCTTGTGGTACTGCCTGATAGGGTG-CTT
AEV     CACTGAAAGGGTATTTTTGGGT-------AATCCTTTCCTACTGCCTGATAGGGTGGCGT
**    * *** * ******          * * *  ***************** * *
HCV     GCGAGTGCCCCGGGAGGTCTCGTAGACCG--TGCACCATG 
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**  * *** ** *** *   *   * *   *  * ****
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Figure 5 
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Figure 6 
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